Alan Howe, Ph.D., professor of pharmacology, has been appointed to serve as associate director of cancer research, training and education coordination for the University of Vermont Cancer Center (UVMCC) .

Christa Zehle, M.D., senior associate dean for medical education, has announced the appointment of Katie Wells, M.D., M.P.H., as the inaugural director of social medicine in the Office of Medical Education at the Larner College of Medicine at the University of Vermont, effective April 3, 2023.

In fall 2022, public health warnings of a possible ”tripledemic” blared across news headlines due to an early-season surge in cases of respiratory syncytial virus (RSV), reported to be the leading cause of infant hospitalizations in the U.S. Sean Diehl, Ph.D., UVM associate professor of microbiology and molecular genetics, is a co-inventor on the patented technology that led to an RSV preventative treatment.

The University of Vermont’s graduating medical students were among a record-breaking nearly 43,000 future physicians participating in the National Resident Matching Program’s 2023 Main Residency Match® on Match Day on March 17.

The Office of Diversity, Equity and Inclusion at the Larner College of Medicine at the University of Vermont hosted the fourth annual Celebration of Gender Equity in Medicine and Science on March 2, 2023.

The University of Vermont’s Center on Rural Addiction has launched a new free program called Clinician Office Hours to help providers access specialists in prevention and treatment of substance abuse disorders. The program is available virtually to any health care provider in the U.S. located in an area designated as rural by the Health Resources & Services Administration.

The University of Vermont’s Larner College of Medicine features some of the world’s foremost cardiovascular researchers, experts in cardiovascular disease risk factors, thrombosis, atherosclerosis, stroke, and heart failure. the science shared by early-career investigators at the Cardiovascular Research Institute of Vermont’s fourth annual Viridis Montis Challenge, it was apparent that the institution’s reputation and legacy in the field of cardiovascular research will continue to have a global impact.

The University of Vermont Cancer Center now offers a novel, highly effective form of cancer treatment called CAR T-cell therapy, and recently began treating patients. The Cancer Center is the only health care institution in Vermont and northern New York to provide the treatment.

A new study published in JAMA Cardiology by UVM cardiovascular medicine fellow Margaret Infeld, M.D., M.S., and colleagues found evidence that by implementing a tailored acceleration of heart rates, they could reduce congestion and improve the circulation of blood in heart failure patients with "stiff" hearts.

Randall F. Holcombe, M.D., M.B.A., director of the UVM Cancer Center and chief of the Division of Hematology and Oncology in the Department of Medicine, has been appointed as associate dean for cancer programs at the UVM Larner College of Medicine.